Log in
Enquire now
‌

US Patent 11371039 Antigen-binding molecule capable of binding to two or more antigen molecules repeatedly

OverviewStructured DataIssuesContributors
Is a
Patent
Patent
Date Filed
September 14, 2020
Date of Patent
June 28, 2022
Patent Application Number
17020543
Patent Citations
‌
US Patent 10233252 pH-dependent antibodies targeting the transferrin receptor and methods of use thereof to deliver a therapeutic agent
‌
US Patent 10253100 Therapeutic antigen-binding molecule with a FcRn-binding domain that promotes antigen clearance
‌
US Patent 10385122 Nucleic acids encoding anti-C5 antibodies
‌
US Patent 10472623 Antigen-binding molecule capable of binding two or more antigen molecules repeatedly
‌
US Patent 10519229 Nucleic acids encoding IL-8 antibodies
‌
US Patent 10662245 Methods of reducing IL-6 activity for disease treatment
‌
US Patent 10618965 Method for altering plasma retention and immunogenicity of antigen-binding molecule
‌
US Patent 10738111 Anti-myostatin antibodies, polypeptides containing variant Fc regions, and methods of use
‌
US Patent 10000560 Anti-myostatin antibodies, polypeptides containing variant Fc regions, and methods of use
‌
US Patent 10024867 Ion concentration-dependent binding molecule library
Patent Citations Received
‌
US Patent 11891434 Antigen-binding molecule capable of binding to plurality of antigen molecules repeatedly
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
11371039
Patent Primary Examiner
‌
Daniel E Kolker

Find more entities like US Patent 11371039 Antigen-binding molecule capable of binding to two or more antigen molecules repeatedly

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.